SARS-CoV-2 vaccines are safe and immunogenic in most people with cancer, according to study
Individuals being treated for active cancer are at particularly high risk of severe disease and death from SARS-CoV-2 infection due to aberrant immune responses from the cancer itself and from some therapies.